Physician profile
Saro Setian
NPI 1578682621
$3,991.92
in general payments reported to CMS, 2019-2025
14 companies · $338 in 2025
The $338 reported for 2025 was more than what 86% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.53 · 2020: $330 · 2021: $213 · 2022: $578 · 2023: $2,395 · 2024: $120 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,053 · Food and Beverage: $1,000 · Entertainment: $500 · Gift: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,053.37 |
| Food and Beverage | $999.53 |
| Entertainment | $500.00 |
| Gift | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,518.64 | 2019-2023 | |
| Patterson Companies, INC. | $765.43 | 2022-2023 | |
| Align Technology, INC. | $506.96 | 2020-2025 | Invisalign, Invisalign System - Moderate, Itero Element |
| Ultradent Products INC | $394.51 | 2022 | |
| Purelife, LLC | $300.00 | 2025 | |
| Centrix INC | $156.16 | 2022 | |
| Straumann USA LLC | $123.42 | 2020 | |
| Voco America INC. | $62.85 | 2021-2025 | Futurabond U, Meron Plus Qm, Admira Fusion X-Base |
| Biolase, INC. | $38.62 | 2020 | |
| Ivoclar Vivadent, INC. | $34.14 | 2020 | |
| Solventum Corporation | $33.44 | 2024 | 3m Filtek |
| Nobel Biocare USA | $30.21 | 2021-2023 | Nobelactive |
| Gc America INC. | $15.87 | 2023 | Coe-Flex |
| Biohorizons Implant Systems INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saro Setian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.